Efficacy and Safety of Switching from Low-Dose Statin to High-Intensity Statin for Primary Prevention in Type 2 Diabetes: A Randomized Controlled Trial
Nuntakorn Thongtang, Jirasak Piyapromdee, Natthakan Tangkittikasem, Kittichai Samaithongcharoen, Nithiwat Srikanchanawat, Sutin Sriussadaporn Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, ThailandCorrespondence: N...
Guardado en:
Autores principales: | Thongtang N, Piyapromdee J, Tangkittikasem N, Samaithongcharoen K, Srikanchanawat N, Sriussadaporn S |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/39eb2b7810c149ce9955e1487e169e7f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Association of Contemporary Statin Pretreatment Intensity and LDL-C Levels on the Incidence of STEMI Presentation
por: Ziv Dadon, et al.
Publicado: (2021) -
Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry
por: Michael G. Nanna, et al.
Publicado: (2018) -
Determinants of Statin Initiation Among Adult Diabetic Patients in Bonga, Ethiopia
por: Kebede zelalem B, et al.
Publicado: (2020) -
Clinical utility of rosuvastatin and other statins for cardiovascular risk reduction among the elderly
por: Sydney B Long, et al.
Publicado: (2010) -
Statins in the primary prevention of cardiovascular disease. Rosuvastatin capabilities
por: Marina G. Bubnova, et al.
Publicado: (2021)